XML 59 R18.htm IDEA: XBRL DOCUMENT v3.19.3
12. SEGMENTS
6 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
SEGMENTS

12. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and Exosome Sciences, Inc., or ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

 

The following tables set forth certain information regarding our segments:

 

   Six Months Ended September 30, 
   2019   2018 
Revenues:        
Aethlon  $30,000   $149,625 
ESI        
Total Revenues  $30,000   $149,625 
           
Operating Losses:          
Aethlon  $(3,256,142)  $(2,369,907)
ESI   (12,249)   (74,319)
Total Operating Loss  $(3,268,391)  $(2,444,226)
           
Net Losses:          
Aethlon  $(3,761,662)  $(2,480,117)
ESI   (12,249)   (74,319)
Net Loss Before Non-Controlling Interests  $(3,773,911)  $(2,554,436)
           
Cash:          
Aethlon  $785,461   $5,076,872 
ESI   197    1,733 
Total Cash  $785,658   $5,078,605 
           
Total Assets:          
Aethlon  $1,281,593   $5,270,690 
ESI   197    1,733 
Total Assets  $1,281,790   $5,272,423 
           
Capital Expenditures:          
Aethlon  $119,981   $ 
ESI        
Capital Expenditures  $119,981   $ 
           
Depreciation and Amortization:          
Aethlon  $5,751   $16,040 
ESI        
Total Depreciation and Amortization  $5,751   $16,040 
           
Interest Expense:          
Aethlon  $(54,106)  $(110,210)
ESI        
Total Interest Expense  $(54,106)  $(110,210)